Fiscus Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Fiscus Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2022	Ansa Biotechnologies	$68.0M Series A	Northpond Ventures, Lily Li	Ayman AlAbdallah, Mei Z., Altitude Life Science Ventures, Blue Water Life Science Advisors, Carbon Silicon Ventures, Codon Capital, Fifty Years, Patrick Zhang, Humboldt Fund, Mubadala Capital, PEAK6 Strategic Capital, RA Capital Management
Nov 10, 2021	Mekonos	$25.0M Series A	Lambert Potin, Elementum Ventures, Fiscus Ventures, Novartis Pharma, PEAK6 Strategic Capital, Reimagined Ventures, Sands Capital, Section 32, Nicolas Sauvage	—
Dec 24, 2020	SomaLogic	$81.0M Series A Extension	Eli Casdin	Amgen Ventures, Boston Millennia Partners, Farallon Capital Management, Foresite Capital, Intermountain Ventures, Janus Henderson Investors, Logos Capital, Madryn Asset Management, Monashee Investment Management, Mossrock Capital, NEC Solution Innovators, Novartis, Redmile Group, Reimagined Ventures, Revelation Partners, Soleus Capital, Roy Smythe, T. Rowe Price Associates, Ziff Capital Partners
Aug 1, 2020	Exo	$40.0M Series B	Action Potential Venture Capital, Fiscus Ventures, Ted Koutouzis MD	Energy Impact Partners, Applied Ventures, Bold Capital, Creative Ventures, Innovation Growth Ventures, Intel Capital, Longevity Vision Fund, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Solasta Ventures, Anil Achyuta, Wanxiang Healthcare Investments